Tags: EU | Switzerland | Novartis | GlaxoSmithKline

Novartis Sells Joint Venture Stake to GSK for $13 Billion

Tuesday, 27 March 2018 02:38 AM

GENEVA (AP) — Swiss pharmaceutical firm Novartis says it is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.

The joint venture was formed in 2015 and Novartis holds a 36.5-percent stake. Novartis CEO Vas Narasimhan said in a statement Wednesday that it "is progressing well," but "the time is right for Novartis to divest a non-core asset at an attractive price."

Novartis said the sale will be a cash transaction, and is subject to the approval of GSK shareholders. The four Novartis-appointed directors on the joint venture's board will step down when the sale is completed.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
GlobalTalk
Swiss pharmaceutical firm Novartis says it is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion.The joint venture was formed in 2015 and Novartis holds a 36.5-percent stake. Novartis CEO Vas Narasimhan said...
EU,Switzerland,Novartis,GlaxoSmithKline
106
2018-38-27
Tuesday, 27 March 2018 02:38 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved